MedTrace Logo

Use Of The ABSS In Infants With ARIS Treated With Outpatient Respiratory Physiotherapy

NCT04036591 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2019-07-30

No results posted yet for this study

Summary

Background. Acute respiratory infections in childhood have high incidence and morbimortality rates, generating significant sanitary and social costs. Due to its diversity of manifestations and clinical forms, the degree of severity varies widely.

Published acute respiratory infections assessment severity scales are mainly focused on acute bronchiolitis, but there is no validated scale to evaluate the effects of respiratory physiotherapy in acute respiratory infections in children.

Objective. To study the usefulness of the Acute Bronchiolitis Severity Scale to assess children under 24 months suffering from acute respiratory infections susceptible to receive outpatient respiratory physiotherapy treatment.

Methods. Pre-post assessment descriptive study using the Acute Bronchiolitis Severity Scale. Children under 24 months suffering from acute respiratory infection will be evaluated during the first outpatient respiratory physiotherapy treatment.

Conditions

  • Acute Disease Respiratory

Interventions

DIAGNOSTIC_TEST

Acute Bronchiolitis Severity Scale (ABSS)

All infants will be assessed using the Acute Bronchiolitis Severity Scale (ABSS) before and after being treated by experienced physiotherapists using the prolonged slow expiration technique and provoqued cough. Before the application of these techniques a retrograde rhinopharyngeal unclogging will be performed in order to clean the nasopharynx.

Sponsors & Collaborators

  • Neumomadrid

    collaborator UNKNOWN

  • Universidad Complutense de Madrid

    collaborator OTHER

  • FisioRespiración

    lead OTHER

Eligibility

Min Age
1 Day
Max Age
24 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-26
Primary Completion
2021-04-30
Completion
2021-05-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04036591 on ClinicalTrials.gov